1. Home
  2. ENTA vs RVSB Comparison

ENTA vs RVSB Comparison

Compare ENTA & RVSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.71

Market Cap

407.5M

Sector

Health Care

ML Signal

HOLD

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

HOLD

Current Price

$5.34

Market Cap

110.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
RVSB
Founded
1995
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
407.5M
110.2M
IPO Year
2013
1993

Fundamental Metrics

Financial Performance
Metric
ENTA
RVSB
Price
$14.71
$5.34
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$20.40
$7.00
AVG Volume (30 Days)
288.3K
42.9K
Earning Date
11-17-2025
01-29-2026
Dividend Yield
N/A
1.50%
EPS Growth
N/A
361.12
EPS
N/A
0.22
Revenue
$65,324,000.00
$52,756,000.00
Revenue This Year
$0.99
$10.25
Revenue Next Year
$0.19
$11.23
P/E Ratio
N/A
$24.23
Revenue Growth
N/A
15.20
52 Week Low
$4.09
$4.74
52 Week High
$15.34
$6.59

Technical Indicators

Market Signals
Indicator
ENTA
RVSB
Relative Strength Index (RSI) 67.09 56.20
Support Level $13.75 $5.01
Resistance Level $14.79 $5.41
Average True Range (ATR) 0.74 0.15
MACD -0.01 0.01
Stochastic Oscillator 90.89 82.50

Price Performance

Historical Comparison
ENTA
RVSB

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

Share on Social Networks: